Scantox Ballerup ApS: Financial statements 2021
CVR: 34724938
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
Scantox Ballerup ApS (CVR 34724938) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 9,621,992 and a net result of DKK 2,325,348 compared with DKK 287,466 the year before. That is an increase of 52.5% compared with the year before. Equity in the 2021 report amounted to DKK 7,078,070. The solvency ratio was 77.3%. The company had 8 employees in the financial year.
- Gross Profit
- DKK 9,621,992
- Profit/Loss
- DKK 2,325,348
- Equity
- DKK 7,078,070
- Total Assets
- DKK 9,159,224
- Employees
- 8
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | 9.6M | 2.3M | 7.1M | 8 |
| 2020 | - | 6.3M | 287K | 5M | 7 |
| 2019 | - | 6.7M | 830K | 4.8M | 7 |
| 2018 | - | 4.9M | -195K | 4.1M | 7 |
| 2017 | - | 10.3M | 3.8M | 4.3M | 6 |
Official annual report
Find more companies like Scantox Ballerup ApS
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2021
Scantox Ballerup ApS has published its annual report for 2020. Gross profit came to DKK 6,310,788, and the net result was DKK 287,466.
About Scantox Ballerup ApS
Scantox Ballerup ApS is a Danish company of the type Anpartsselskab based in Ballerup, founded in 2012. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named SOLURAL PHARMA ApS. The management consists of Helle Kirstein Erichsen. The board consists of Jeanet Løgsted Nielsen (chair) and Emil Staal Bergander. The company is owned by Scantox Denmark ApS. The company has 14 employees (2026). In 2025, the company reported a gross profit of DKK 13,349,106 and a net result of DKK -1,931,049 compared with DKK 255,010 the year before. Equity in the 2025 report amounted to DKK -1,539,321.